Stability of extemporaneously prepared moxifloxacin oral suspensions.
OBJECTIVE
The stability of extemporaneously prepared moxifloxacin oral suspensions was studied.


METHODS
An oral suspension of moxifloxacin 20 mg/mL was prepared by thoroughly grinding three 400-mg tablets of moxifloxacin in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of either Ora-Sweet or Ora-Sweet SF were mixed and added to the powder to make a final volume of 60 mL. Three identical samples of each formulation were prepared and placed in 2-oz amber plastic bottles with child-resistant caps and were stored at room temperature (23-25 degrees C). A 1-mL sample was withdrawn from each of the six bottles with a micropipette immediately after preparation and at 7, 14, 28, 60, and 90 days. After further dilution to an expected concentration of 8 microg/ mL with sample diluent, the samples were assayed in duplicate by stability-indicating high-performance liquid chromatography. Stability was defined as the retention of at least 90% of the initial concentration.


RESULTS
At least 99% of the initial moxifloxacin remained throughout the 90-day study period in both preparations. There were no detectable changes in color, odor, taste, and pH and no visible microbial growth in any sample.


CONCLUSIONS
Extemporaneously compounded suspensions of moxifloxacin 20 mg/mL in a 1:1 mixture of Ora-Plus and Ora-Sweet or Ora-Sweet SF were stable for at least 90 days when stored in 2-oz amber plastic bottles at room temperature.
Hutchinson
David J
DJ
Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY, USA.
Johnson
Cary E
CE
Klein
Kristin C
KC
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000737:chemistry*; D001372:Aza Compounds / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D004339:Drug Compounding; D004355:Drug Stability; D004356:Drug Storage; D024841:Fluoroquinolones / Q000737:chemistry; D000077266:Moxifloxacin; D014677:Pharmaceutical Vehicles; D011804:Quinolines / Q000737:chemistry*; D013535:Suspensions; D013607:Tablets
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D014677:Pharmaceutical Vehicles; D011804:Quinolines; D013535:Suspensions; D013607:Tablets; D000077266:Moxifloxacin